Early Access Care serves patients with life-threatening conditions, their families and caregivers, treating physicians, and biopharmaceutical companies. We facilitate expanded access to investigational medicines for those who exhaust standard treatments, supporting healthcare providers through regulatory processes and helping companies deliver compassionate use programs globally.